Bruno Ragazzon chercheur
Ragazzon, Bruno, 1977-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 192869498 (Personal)
Permalink: http://viaf.org/viaf/192869498
Preferred Forms
-
100 0 _
‡a
Bruno Ragazzon
‡c
chercheur
-
100 1 _
‡a
Ragazzon, Bruno
‡d
1977-...
-
100 1 _
‡a
Ragazzon, Bruno,
‡d
1977-....
4xx's: Alternate Name Forms (4)
Works
| Title | Sources |
|---|---|
| 8Cl-cAMP modifies the balance between PKAR1 and PKAR2 and modulates the cell cycle, growth and apoptosis in human adrenocortical H295R cells. |
|
| ACTH and PRL sensitivity of highly differentiated cell lines obtained by adrenocortical targeted oncogenesis. |
|
| Adrenocorticotropin/3',5'-cyclic AMP-mediated transcription of the scavenger akr1-b7 gene in adrenocortical cells is dependent on three functionally distinct steroidogenic factor-1-responsive elements |
|
| Aldo keto reductase 1B7 and prostaglandin F2alpha are regulators of adrenal endocrine functions |
|
| AXIN genetic analysis in adrenocortical carcinomas updated |
|
| Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma |
|
| Comparison of the effects of PRKAR1A and PRKAR2B depletion on signaling pathways, cell growth, and cell cycle control of adrenocortical cells |
|
| A concomitant false-negative ¹⁸F-FDG PET imaging in an adrenocortical carcinoma and a high uptake in a corresponding liver metastasis. |
|
| Cushing's syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice |
|
| Dosage-dependent regulation of VAV2 expression by steroidogenic factor-1 drives adrenocortical carcinoma cell invasion. |
|
| Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma |
|
| High Diagnostic and Prognostic Value of Steroidogenic Factor-1 Expression in Adrenal Tumors |
|
| Hormonal control of adrenocortical steroidogenesis and tumorigenesis by the use of transgenic mice for the development of new cell lines and animal models of tumoral pathologies by targeted oncogenesis. |
|
| Identification of a CpG island methylator phenotype in adrenocortical carcinomas |
|
| Identification of gene expression profiles associated with cortisol secretion in adrenocortical adenomas. |
|
| IGF2 promotes growth of adrenocortical carcinoma cells, but its overexpression does not modify phenotypic and molecular features of adrenocortical carcinoma. |
|
| Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. |
|
| Inactivation of the Carney complex gene 1 |
|
| Lack of the presynaptic RhoGAP protein oligophrenin1 leads to cognitive disabilities through dysregulation of the cAMP/PKA signalling pathway. |
|
| Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation |
|
| Novel Grb14-Mediated Cross Talk between Insulin and p62/Nrf2 Pathways Regulates Liver Lipogenesis and Selective Insulin Resistance |
|
| Novel Insights into the Genetics and Pathophysiology of Adrenocortical Tumors |
|
| Pancreatic ductal and acinar cell neoplasms in Carney complex: a possible new association |
|
| Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors |
|
| PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease. |
|
| Rôle de la protéine kinase AMPc-dépendante de type I dans le couplage excitation-contraction et l'insuffisance cardiaque |
|
| Rôle de la signalisation PKA dans la zonation de la glande surrénale : modèles génétiques murins et mécanismes post-traductionnels |
|
| Rôle des voies de signalisation AMPc/PKA et Wnt/beta-caténine dans la formation des systèmes de régulation aberrants au sein de la corticosurrénale |
|
| Role of cAMP/PKA and Wnt/beta-catenin signaling pathways in the occurrence of aberrant regulatory systems within the adrenal cortex. |
|
| Role of PKA signaling in adrenocortical zonation : transgenic mouse models and post-translational mechanisms. |
|
| Rôles des altérations des gènes CTNNB1 et de ZNRF3 dans les carsinomes de la corticosurrénale |
|
| Rspondin signaling in adrenal gland development and homeostasis. |
|
| Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R. |
|
| TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors |
|
| Transcriptome analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive adrenocortical cancers. |
|
| A transgenic mouse line with specific Cre recombinase expression in the adrenal cortex |
|
| Tumorigenèse, progression tumorale et zonation fonctionnelle du cortex surrénalien |
|
| Vascular and hormonal interactions in primary aldosteronism. |
|
| Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors |
|
| WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production |
|
| β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma |
|
